The blood-brain barrier and oncology: new insights into function and modulation
- 1 December 2000
- journal article
- review article
- Published by Elsevier BV in Cancer Treatment Reviews
- Vol. 26 (6), 449-462
- https://doi.org/10.1053/ctrv.2000.0194
Abstract
No abstract availableThis publication has 149 references indexed in Scilit:
- Cereport® (RMP-7) increases carboplatin levels in brain tumors after pretreatment with dexamethasoneNeuro-Oncology, 1999
- Reversal of MRP-Mediated Multidrug Resistance in Human Lung Cancer Cells by the Antiprogestatin Drug RU486Biochemical and Biophysical Research Communications, 1999
- Role of P‐Glycoprotein in the Blood‐Brain Transport of Colchicine and VinblastineJournal of Neurochemistry, 1996
- Effect of the P-Glycoprotein Inhibitor, Cyclosporine A, on the Distribution of Rhodamine-123 to the Brain: An in Vivo Microdialysis Study in Freely Moving RatsBiochemical and Biophysical Research Communications, 1995
- Neurological complications of organ transplantationAnnals of Neurology, 1994
- Carboplatin as second line treatment for recurrent or progressive brain metastases from small cell lung cancerEuropean Journal Of Cancer, 1993
- Intra-arterial mannitol infusion in the chemotherapy for malignant brain tumorsJournal of Neuro-Oncology, 1993
- Development of blood vessel-related radiation damage in the fimbria of the central nervous systemInternational Journal of Radiation Oncology*Biology*Physics, 1990
- CyclosporineNew England Journal of Medicine, 1989
- Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: A study using quail-chick transplantation chimerasDevelopmental Biology, 1981